140 related articles for article (PubMed ID: 38100938)
41. Live birth after single embryo transfer of autologous cryopreserved oocytes from a patient with myelodysplastic syndrome who underwent allogenic peripheral blood stem cell transplantation.
Tsai YY; Chen SU; Shieh CJ; Yao YL; Yang YS; Chen CD
J Formos Med Assoc; 2014 Dec; 113(12):966-9. PubMed ID: 25294099
[TBL] [Abstract][Full Text] [Related]
42. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
[TBL] [Abstract][Full Text] [Related]
43. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
44. Breast Cancer and Fertility Preservation in Young Female Patients: A Systematic Review of the Literature.
Boutas I; Kontogeorgi A; Koufopoulos N; Dimas DT; Sitara K; Kalantaridou SN; Dimitrakakis C
Clin Pract; 2023 Nov; 13(6):1413-1426. PubMed ID: 37987428
[TBL] [Abstract][Full Text] [Related]
45. The Experience of Fertility Preservation in a Single Tertiary Center in Korea.
Choi YJ; Hong YH; Kim S; Kim SK; Lee JR; Suh CS
Front Endocrinol (Lausanne); 2022; 13():845051. PubMed ID: 35518927
[TBL] [Abstract][Full Text] [Related]
46. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.
Oktay K; Buyuk E; Rodriguez-Wallberg KA; Sahin G
Reprod Biomed Online; 2010 May; 20(5):634-8. PubMed ID: 20219430
[TBL] [Abstract][Full Text] [Related]
47. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
[TBL] [Abstract][Full Text] [Related]
48. Fertility preservation in breast cancer patients.
El Hachem H; Atallah D; Grynberg M
Future Oncol; 2014 Aug; 10(10):1767-77. PubMed ID: 25303056
[TBL] [Abstract][Full Text] [Related]
49. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
[TBL] [Abstract][Full Text] [Related]
50. A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients.
Sanada Y; Harada M; Kunitomi C; Kanatani M; Izumi G; Hirata T; Fujii T; Suzuki N; Morishige KI; Aoki D; Irahara M; Tsugawa K; Tanimoto M; Nishiyama H; Hosoi H; Sugiyama K; Kawai A; Osuga Y
J Obstet Gynaecol Res; 2019 Oct; 45(10):2021-2028. PubMed ID: 31364239
[TBL] [Abstract][Full Text] [Related]
51. Ovarian protection and fertility preservation in women with cancer: A French national registry analysis between 2005 and 2014.
Phelippeau J; Cazalis CG; Koskas M
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):705-710. PubMed ID: 31276847
[TBL] [Abstract][Full Text] [Related]
52. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer.
Martinez M; Rabadan S; Domingo J; Cobo A; Pellicer A; Garcia-Velasco JA
Reprod Biomed Online; 2014 Dec; 29(6):722-8. PubMed ID: 25444506
[TBL] [Abstract][Full Text] [Related]
53. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B
Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038
[TBL] [Abstract][Full Text] [Related]
54. Cryobiology in human assisted reproductive technology. Would Hippocrates approve?
Bredkjaer HE; Grudzinskas JG
Early Pregnancy (Cherry Hill); 2001 Jul; 5(3):211-3. PubMed ID: 11753534
[TBL] [Abstract][Full Text] [Related]
55. Cryopreservation of human embryos and oocytes for fertility preservation in cancer and non cancer patients: a mini review.
Sciorio R
Gynecol Endocrinol; 2020 May; 36(5):381-388. PubMed ID: 32003268
[TBL] [Abstract][Full Text] [Related]
56. Survey of Reproductive Experiences and Outcomes of Cancer Survivors Who Stored Reproductive Material Before Treatment.
Hammarberg K; Kirkman M; Stern C; McLachlan RI; Clarke G; Agresta F; Gook D; Rombauts L; Vollenhoven B; Fisher JRW
Hum Reprod; 2017 Dec; 32(12):2423-2430. PubMed ID: 29045667
[TBL] [Abstract][Full Text] [Related]
57. The experiences of women with breast cancer who undergo fertility preservation.
Dahhan T; van der Veen F; Bos AME; Goddijn M; Dancet EAF
Hum Reprod Open; 2021; 2021(2):hoab018. PubMed ID: 33959685
[TBL] [Abstract][Full Text] [Related]
58. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
[TBL] [Abstract][Full Text] [Related]
59. [Oncofertility and breast cancer].
Sonigo C; Grynberg M; Bringer S; Sermondade N
Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
[TBL] [Abstract][Full Text] [Related]
60. Fertility preservation options for female patients with malignancies.
Seli E; Tangir J
Curr Opin Obstet Gynecol; 2005 Jun; 17(3):299-308. PubMed ID: 15870565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
